[Histiocytosis X. Clinical aspects and therapy].
D000963:Antimetabolites / Q000627:therapeutic use; D001847:Bone Diseases / Q000473:pathology; D002908:Chronic Disease; D003919:Diabetes Insipidus / Q000209:etiology; D004803:Eosinophilic Granuloma / Q000473:pathology; D005094:Exophthalmos / Q000209:etiology; D006646:Histiocytosis, Langerhans-Cell / Q000473:pathology; D006801:Humans; D008171:Lung Diseases / Q000473:pathology; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000209:etiology; D011660:Pulmonary Heart Disease / Q000209:etiology; D011782:Quadriplegia / Q000209:etiology; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000963:Antimetabolites; D014748:Vinca Alkaloids
Histiocytosis X. Klinik und Therapie.